China National Accord Medicines Corp Ltd Total Liabilities

Latest as of March 2026: HK$27.21 Billion HKD ≈ $3.47 Billion USD

China National Accord Medicines Corp Ltd total liabilities. Based on the latest financial reports, China National Accord Medicines Corp Ltd (200028) has total liabilities worth HK$27.21 Billion HKD (≈ $3.47 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of China National Accord Medicines Corp Ltd to evaluate the company's liquid asset resilience ratio.

Total Liabilities of China National Accord Medicines Corp Ltd (1992–2025)

Total liabilities of China National Accord Medicines Corp Ltd from 1992 to 2025. This chart illustrates how China National Accord Medicines Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore China National Accord Medicines Corp Ltd (200028) investment intensity to see how much of total assets are deployed in long-term investments.

China National Accord Medicines Corp Ltd Competitors by Total Liabilities

The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Taiwan Fructose Co Ltd TWO:4207	Taiwan	NT$2.74 Billion
Group Eleven Resources Corp V:ZNG	Canada	CA$940.88K
Grigeo AB STU:WM8	Germany	€76.06 Million
Mega Uranium Ltd. TO:MGA	Canada	CA$34.20 Million
Carnarvon Energy Ltd AU:CVN	Australia	AU$4.79 Million
Global Dividend Growth Split Corp Class A TO:GDV	Canada	CA$167.00 Million
Securitag Assembly Group Co Ltd TWO:6417	Taiwan	NT$1.21 Billion
Avita Medical Ltd NASDAQ:RCEL	USA	$73.04 Million

Liability Composition Analysis (1992–2025)

This chart breaks down China National Accord Medicines Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 200028 asset base.

Liquidity & Leverage Metrics

China National Accord Medicines Corp Ltd Total Liabilities Ratios Explained

China National Accord Medicines Corp Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.56	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.44	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.55	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how China National Accord Medicines Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for China National Accord Medicines Corp Ltd (1992–2025)

The table below shows the annual total liabilities of China National Accord Medicines Corp Ltd from 1992 to 2025.

Year	Total Liabilities	Change
2025-12-31	HK$27.47 Billion ≈ $3.51 Billion	+2.50%
2024-12-31	HK$26.80 Billion ≈ $3.42 Billion	+0.78%
2023-12-31	HK$26.59 Billion ≈ $3.39 Billion	+14.77%
2022-12-31	HK$23.17 Billion ≈ $2.96 Billion	-6.42%
2021-12-31	HK$24.76 Billion ≈ $3.16 Billion	+9.05%
2020-12-31	HK$22.71 Billion ≈ $2.90 Billion	+25.03%
2019-12-31	HK$18.16 Billion ≈ $2.32 Billion	+20.87%
2018-12-31	HK$15.02 Billion ≈ $1.92 Billion	+21.01%
2017-12-31	HK$12.42 Billion ≈ $1.58 Billion	+0.14%
2016-12-31	HK$12.40 Billion ≈ $1.58 Billion	+62.04%
2015-12-31	HK$7.65 Billion ≈ $976.79 Million	-4.08%
2014-12-31	HK$7.98 Billion ≈ $1.02 Billion	-8.73%
2013-12-31	HK$8.74 Billion ≈ $1.12 Billion	+17.23%
2012-12-31	HK$7.46 Billion ≈ $951.89 Million	+19.52%
2011-12-31	HK$6.24 Billion ≈ $796.43 Million	+20.55%
2010-12-31	HK$5.18 Billion ≈ $660.65 Million	+18.83%
2009-12-31	HK$4.36 Billion ≈ $555.98 Million	+43.52%
2008-12-31	HK$3.03 Billion ≈ $387.38 Million	+27.05%
2007-12-31	HK$2.39 Billion ≈ $304.90 Million	+8.26%
2006-12-31	HK$2.21 Billion ≈ $281.65 Million	+225.07%
2005-12-31	HK$678.73 Million ≈ $86.64 Million	+39.09%
2004-12-31	HK$487.99 Million ≈ $62.29 Million	-26.67%
2003-12-31	HK$665.47 Million ≈ $84.95 Million	-7.30%
2002-12-31	HK$717.90 Million ≈ $91.64 Million	-4.75%
2001-12-31	HK$753.72 Million ≈ $96.21 Million	+778.18%
2000-12-31	HK$85.83 Million ≈ $10.96 Million	-1.03%
1999-12-31	HK$86.72 Million ≈ $11.07 Million	-24.01%
1998-12-31	HK$114.11 Million ≈ $14.57 Million	-31.94%
1997-12-31	HK$167.66 Million ≈ $21.40 Million	+87.37%
1996-12-31	HK$89.48 Million ≈ $11.42 Million	+77.00%
1995-12-31	HK$50.55 Million ≈ $6.45 Million	-11.09%
1994-12-31	HK$56.85 Million ≈ $7.26 Million	-41.32%
1993-12-31	HK$96.88 Million ≈ $12.37 Million	+4.01%
1992-12-31	HK$93.14 Million ≈ $11.89 Million	--

About China National Accord Medicines Corp Ltd

SHE:200028 China Medical Distribution

Market Cap

$126.64 Million

HK$992.07 Million HKD

Market Cap Rank

#18074 Global

#4658 in China

Share Price

HK$12.64

Change (1 day)

-0.24%

52-Week Range

HK$11.60 - HK$14.07

All Time High

HK$1125.97